Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Carleton University

$33,000.00

Effecting accuracy in dosimetry measurements for FLASH radiotherapy beams

EF 2023-24

Résumé
Over the course of their treatment, more than 100,000 Canadian cancer patients receive radiation therapy every year.1 The output of the units used to deliver such treatments is determined using detectors traceable to absorbed dose (energy/mass) standards maintained at the National Research Council (NRC). New radiation therapy techniques are under development that employ extremely fast treatment delivery, known as FLASH radiotherapy. FLASH radiotherapy induces a biological phenomenon known as the FLASH effect, whereby the ultra-high dose rate radiation reduces normal tissue toxicities commonly associated with conventional radiotherapy, while still maintaining local tumor control.2 Therefore, FLASH beam modalities have the potential to significantly improve the treatment of certain types of cancer at relatively low economic cost. However, conventional radiation detectors have been shown to perform poorly for absorbed dose measurements for FLASH radiotherapy delivery devices.3 Using conventional clinical detectors and typical assumptions will result in errors on the order of 10 % or larger for dose measurements in FLASH radiotherapy beams.4 Lack of accurate and reliable absorbed dose measurements for FLASH treatment devices is a limiting factor to realize the FLASH technique as an enabling technology through small animal studies and patient trials. In order for FLASH radiotherapy (RT) to be useful for improving patient treatment outcomes, there are dosimetry challenges that must be addressed. This research program will develop techniques to determine accurate dose measurements for FLASH radiotherapy beams. Four promising avenues of research will be pursued: (1) the application of conventional absolute dose measurement devices (calorimeters) to FLASH beams, (2) the development of novel dose measurement devices (pyroelectric calorimeters) that can be read out with conventional clinical equipment, (3) a robust solution for FLASH beam output monitoring during patient treatment delivery, and (4) the investigation of a chemical dosimeter that can be used for dose verification audits and relative dose measurements. The outputs of this research program will be translated to the radiation therapy community through collaborative research engagements to enable real impacts on small animal studies, patient trials, and eventually, routine patient treatments. There are already four clinical sites in Canada with FLASH radiotherapy capabilities and several more clinics are expected to establish these capabilities in the next year. The research proposed here will be carried out in concert with these Canadian cancer centres, and has the potential to directly improve the quality and outcomes of cancer treatments for Canadians.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2023-04659
Name nom
Muir, Bryan
Department département
Metrology Research Centre
Organization id
23
Institution établissement
Carleton University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3108
Research subject group en
Physics
Research subject group fr
Experimental methods and instrumentation
Research subject en
Physique
Research subject fr
Méthodes expérimentales et instrumentation
Application title
Effecting accuracy in dosimetry measurements for FLASH radiotherapy beams
Keyword
beam current monitor; calorimetry; cancer; clinical; dosimetry; electrometer; FLASH radiation therapy; pyroelectric; radiation therapy; ultra-high dose per pulse
Application summary
Over the course of their treatment, more than 100,000 Canadian cancer patients receive radiation therapy every year.1 The output of the units used to deliver such treatments is determined using detectors traceable to absorbed dose (energy/mass) standards maintained at the National Research Council (NRC). New radiation therapy techniques are under development that employ extremely fast treatment delivery, known as FLASH radiotherapy. FLASH radiotherapy induces a biological phenomenon known as the FLASH effect, whereby the ultra-high dose rate radiation reduces normal tissue toxicities commonly associated with conventional radiotherapy, while still maintaining local tumor control.2 Therefore, FLASH beam modalities have the potential to significantly improve the treatment of certain types of cancer at relatively low economic cost. However, conventional radiation detectors have been shown to perform poorly for absorbed dose measurements for FLASH radiotherapy delivery devices.3 Using conventional clinical detectors and typical assumptions will result in errors on the order of 10 % or larger for dose measurements in FLASH radiotherapy beams.4 Lack of accurate and reliable absorbed dose measurements for FLASH treatment devices is a limiting factor to realize the FLASH technique as an enabling technology through small animal studies and patient trials. In order for FLASH radiotherapy (RT) to be useful for improving patient treatment outcomes, there are dosimetry challenges that must be addressed. This research program will develop techniques to determine accurate dose measurements for FLASH radiotherapy beams. Four promising avenues of research will be pursued: (1) the application of conventional absolute dose measurement devices (calorimeters) to FLASH beams, (2) the development of novel dose measurement devices (pyroelectric calorimeters) that can be read out with conventional clinical equipment, (3) a robust solution for FLASH beam output monitoring during patient treatment delivery, and (4) the investigation of a chemical dosimeter that can be used for dose verification audits and relative dose measurements. The outputs of this research program will be translated to the radiation therapy community through collaborative research engagements to enable real impacts on small animal studies, patient trials, and eventually, routine patient treatments. There are already four clinical sites in Canada with FLASH radiotherapy capabilities and several more clinics are expected to establish these capabilities in the next year. The research proposed here will be carried out in concert with these Canadian cancer centres, and has the potential to directly improve the quality and outcomes of cancer treatments for Canadians.